Campora E - Search Results

1

A retrospective comparison of detection and treatment of breast cancer in young and elderly patients.

Repetto L, Costantini M, Campora E, Amoroso D, Gianni W, Catturich A, Vecchio C, Simoni C, Marigliano V, Rosso R, Santi L. Repetto L, et al. Among authors: campora e. Breast Cancer Res Treat. 1997 Mar;43(1):27-31. doi: 10.1023/a:1005784208787. Breast Cancer Res Treat. 1997. PMID: 9065596

2

Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach.

Gardin G, Rosso R, Campora E, Repetto L, Naso C, Canavese G, Catturich A, Corvò R, Guenzi M, Pronzato P, et al. Gardin G, et al. Among authors: campora e. Eur J Cancer. 1995;31A(9):1428-33. doi: 10.1016/0959-8049(95)00199-s. Eur J Cancer. 1995. PMID: 7577066

3

Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer.

Gardin G, Alama A, Rosso R, Campora E, Repetto L, Pronzato P, Merlini L, Naso C, Camoriano A, Meazza R, et al. Gardin G, et al. Among authors: campora e. Breast Cancer Res Treat. 1994;32(3):311-8. doi: 10.1007/BF00666008. Breast Cancer Res Treat. 1994. PMID: 7865857

4

Mitoxantrone in elderly women with advanced breast cancer: a phase II study.

Repetto L, Simoni C, Venturino A, Biancardi V, Gasco M, Campora E, Rosso R. Repetto L, et al. Among authors: campora e. Anticancer Res. 1995 Sep-Oct;15(5B):2297-300. Anticancer Res. 1995. PMID: 8572641 Clinical Trial.

5

Tamoxifen and interferon-beta for the treatment of metastatic breast cancer.

Repetto L, Giannessi PG, Campora E, Pronzato P, Vigani A, Naso C, Spinelli I, Conte PF, Rosso R. Repetto L, et al. Among authors: campora e. Breast Cancer Res Treat. 1996;39(2):235-8. doi: 10.1007/BF01806190. Breast Cancer Res Treat. 1996. PMID: 8872332 Clinical Trial.

6

The impact of chemotherapy on the quality of life of breast cancer patients.

Campora E, Naso C, Vitullo MT, Giudici S, Camoirano A, Repetto L, Rosso R. Campora E, et al. J Chemother. 1992 Feb;4(1):59-63. doi: 10.1080/1120009x.1992.11739141. J Chemother. 1992. PMID: 1383437

7

Prognostic factors in node positive primary breast cancer patients treated with adjuvant CMF.

Campora E, Pronzato P, Amoroso D, Bertelli GF, Venturini M, Baldini E, Brunetti I, Sertoli MR, Conte P, Rosso R. Campora E, et al. Anticancer Res. 1992 Sep-Oct;12(5):1555-8. Anticancer Res. 1992. PMID: 1444221

8

Oral ondansetron (GR 38032F) for the control of CMF-induced emesis in the outpatient.

Campora E, Oliva C, Mammoliti S, Cetto GL, Fosser V, Marangolo M, Rosso R. Campora E, et al. Breast Cancer Res Treat. 1991 Oct;19(2):129-32. doi: 10.1007/BF01980943. Breast Cancer Res Treat. 1991. PMID: 1836746 Clinical Trial.

9

Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer.

Repetto L, Miglietta L, Gardin G, Lanfranco C, Naso C, Merlini L, Giudici S, Venturino A, Campora E, Testore F, et al. Repetto L, et al. Among authors: campora e. Breast Cancer Res Treat. 1994;30(2):133-7. doi: 10.1007/BF00666056. Breast Cancer Res Treat. 1994. PMID: 7949211 Clinical Trial.

10

[Tropisetron versus ondansetron in the prevention and control of emesis in patients undergoing chemotherapy with FAC/FEC for metastatic or surgically treated breast carcinoma].

Campora E, Simoni C, Rosso R. Campora E, et al. Minerva Med. 1994 Jan-Feb;85(1-2):25-31. Minerva Med. 1994. PMID: 8152575 Clinical Trial. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters